Tag: Dr Krishna Ella

Developed in collaboration with ICAR, BIOLUMPIVAXIN® is also India’s first LSD Vaccine

The state-of-the-art vaccine manufacturing plant is built to produce 10 different vaccines, and create more than 2000 direct jobs and 1500 indirect employment opportunities

Bharat Biotech's Founder & Executive Chairman has been recognized for his contributions to new knowledge, discoveries and development of new vaccine technologies

Dr Krishna Ella, Executive Chairman, Bharat Biotech and President, IVMA shares his insights on the industry’s journey so far and the future potential.

Strategic Collaboration Aims to Accelerate Global Access to Potentially Life-Saving Vaccine

The Cover Story focuses on India's crucial role in ensuring global vaccine security with an exclusive interview of Dr Krishna Ella, Executive Chairman, Bharat Biotech & President, Indian Vaccine Manufacturers Association. Read interviews of Sriram Natarajan, CEO, Molbio Diagnostics and Dr Renuka Diwan, CEO, BioPrime Agrisolutions. Also features Expert Insights, Special Story and Startup Special.

Bharat Biotech's collaboration with MSD, Wellcome-Trust Hilleman Laboratories aims to address the critical shortage of OCVs

The Supreme Court considered the arguments on merits and dismissed the writ petition on the ground that this is a roving inquiry and the petitioner failed to disclose the entire facts before the Court

The Dean's Medal recognises exceptional leadership in safeguarding and improving global public health

Dr Ella takes over the Presidency from Mr. Adar C Poonawala who held the post from 2019 to March 2024